Phase III long-term safety study of Effexor XR in patients with major depression.
..Date First Received: September 12, 2005
Last Updated: May 22, 2007
Verified by: Wyeth, May 2007
Clinical Trial Phase: Phase 3 | Start Date: September 2004
Overall Status: Completed
Estimated Enrollment: 150
Brief Summary
Official Title: “Phase III Long-Term Administration Study of Effexor XR for the Treatment of Depression”
Condition Keyword(s):
Additional Keyword(s) Provided by Sponsor:
Intervention(s):
Condition MeSH Term(s), Assigned with an Experimental Algorithm:
Intervention MeSH Term(s), Assigned with an Experimental Algorithm:
Phase III long-term safety study of Effexor XR in patients with major depression.
Study Type: Interventional
Study Design: Allocation: Non-Randomized, Control: Uncontrolled, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention(s) in this Clinical Trial
- Drug: Effexor XR
Outcome Measures for this Clinical Trial
Primary Measures
- Incidence of adverse events
Secondary Measures
- Quantitative data for laboratory data
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients who complete the Phase III double-blind study (Protocol Number 0600B1-816)
Exclusion Criteria:
- Patients with schizophrenia or any other psychotic disorder
- Patients with history or presence of bipolar disorder
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 20 Years
Maximum Age for this Clinical Trial: 65 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Wyeth
Overall Clinical Trial Officials and Contacts
Medical Monitor Study Director Wyeth
Additional Information
Information obtained from ClinicalTrials.gov on September 07, 2010
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00225524
Study ID Number: 0600B1-818
ClinicalTrials.gov Identifier: NCT00225524
Health Authority: Japan: Pharmaceuticals and Medical Devices Agency
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
